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Introduction
Patients undergoing cardiac and abdominal surgery are at 
risk of postoperative pulmonary complications. The rate 
of postoperative pulmonary complications depends on 
the organ being operated on, the presence of risk factors, 
and the criteria used to define a postoperative pulmonary 
complication. Cardiac and upper abdominal surgical 
procedures are associated with a high incidence (17–88%) 
of postoperative pulmonary complications (Overend et 
al 2001). The basic mechanism of these complications 
involves: i) lack of lung inflation due to postoperative 
pain, resulting in a shallow, monotonous breathing pattern 
without periodic sighs, ii) prolonged recumbent positioning, 
and iii) temporary diaphragmatic dysfunction. Mucociliary 
clearance is also impaired postoperatively which, along 
with a decrease in cough effectiveness, increases the risks 
associated with retained pulmonary secretions (Overend et 
al 2001).
Postoperative pulmonary complications among patients 
undergoing cardiac and abdominal surgery increase 
mortality and contribute to longer stays in hospital and 
intensive care (Lawrence et al 1995, Moyer 1994, Johnson 
and McMahan 1997, Schuller and Morrow 2000). Reports 
of the incidence of postoperative pulmonary complications 
after cardiac and upper abdominal surgery vary widely 
(Overend et al 2001, Jensen and Yang 2007, Wynne et al 
2004). This variability depends in part on the organ being 
operated on and the presence of risk factors, and in part 
on the criteria used to define a postoperative pulmonary 
complication. It is therefore important to estimate the 
incidence of clearly defined pulmonary complications after 
specific surgical procedures accurately. It may also be of 
interest to compare particular classes of complications, 
such as pulmonary versus pleural.
Although abdominal surgery has been studied extensively in 
this regard (Overend et al 2001), only one study has reported 
the risk factors for postoperative pulmonary complications 
after coronary artery bypass grafting (Hulzebos 2003). 
No studies have previously investigated the risk factors for 
postoperative pulmonary complications after aortic valve 
replacement. Nevertheless, aortic valve replacement is 
increasing (Ambler et al 2005, Mistiaen et al 2007). With 
it, age and non-cardiac morbidity in patients referred for 
surgery have also been shown to be increasing (Mistiaen et 
al 2007). Postoperative pulmonary complications are likely 
to remain important in aortic valve replacement because 
– in contrast to coronary surgery – the procedure always 
requires the use of extracorporeal circulation with all its 
side effects on the respiratory system (Wynne and Botti 
2004).
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Question: What factors predict postoperative pulmonary and pleural complications following aortic valve replacement? 
Design: Retrospective study. Participants: One thousand consecutive patients who underwent aortic valve replacement 
with a pericardial valve between 1986 and 2006. Of these, 610 underwent also coronary artery surgery. Outcome measures: 
Thirty putative predictors were investigated. Postoperative pulmonary complications (defined as respiratory failure, pneumonia, 
atelectasis) and postoperative pleural complications (defined as pleural effusion, pneumothorax, haemothorax, empyema) 
within 30 days of surgery were identified. Results: 58 (6%) patients developed pulmonary complications and 45 (5%) developed 
pleural complications. None of the pleural and only 3 of the pulmonary complications were fatal if they occurred alone. 
Postoperative heart failure (OR 4.7, 95% CI 1.8 to 11.9), previous pacemaker implant (OR 4.4, 95% CI 1.8 to 11.2) and chronic 
obstructive pulmonary disease (OR 1.7, 95% CI 1.0 to 3.1) independently predicted postoperative pulmonary complications. 
Postoperative bleeding (OR 7.4, 95% CI 1.8 to 29.9), carotid artery disease (OR 2.8, 95% CI 1.4 to 5.5), previous coronary 
artery surgery (OR 2.7, 95% CI 1.1 to 6.4), chronic obstructive pulmonary disease (OR 1.9, 95% CI 1.0 to 3.8) and cardiac 
conduction defect (OR 1.9, 95% CI 1.0 to 3.7) independently predicted postoperative pleural complications. Conclusions: 
Postoperative pulmonary and pleural complications were rare. A history of cardiac and/or pulmonary problems are risk factors 
for pulmonary complications after aortic valve replacement. Further study is needed to reveal if preventive physiotherapeutic 
intervention in these patients is effective. [Mistiaen W, Vissers D (2008) The risk of postoperative pulmonary or pleural 
complications after aortic valve replacement is low in elderly patients: an observational study. Australian Journal of 
Physiotherapy 54: 119–124]
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The research questions for this study were:
What is the incidence of postoperative pulmonary and 1. 
pleural complications after aortic valve replacement?
What factors predict postoperative pulmonary compli-2. 
cations following aortic valve replacement?
What factors predict postoperative pleural compli-3. 
cations following aortic valve replacement?
Knowledge of the risk factors for postoperative compli-
cations should be helpful in designing clinical trials of 
prevention.
Method
Design
A retrospective study of patients undergoing aortic valve 
replacement between 1986 and 2006 was conducted. The 
operation itself had not changed (type of extracorporeal 
circulation, surgical method of valve implantation) over the 
20 years. In 1996, the anaesthetic and analgesic regimens 
were changed. Full-day postoperative narcosis with high 
dose opiates was replaced by short track anaesthesia with 
extubation within 6 hours of surgery, a lower dose of opiates, 
and an increase in inhalation anaesthetics. Minor changes 
Table 1. Number (%) of patients with pulmonary complications (n = 58) as a proportion of those with and without  
and odds ratios (95% CI) between them for each putative predictor.
Putative predictors Groups Odds ratios between 
groups
Number with 
pulmonary 
complications/ 
number with 
putative predictor
Number with 
pulmonary 
complications/ 
number without 
putative predictor
Proportion of pulmonary 
complications with 
predictor present 
relative to those with 
predictor absent
Preoperative
Pacemaker implant 7/33 (21) 50/957 (5) 4.9 (1.8 to 12.4)
COPD 21/235 (9) 34/732 (5) 2.0 (1.1 to 3.7)
BMI >25 13/179 (7) 3/134 (2) 3.4 (0.9 to 11.2)
Conduction defect 20/270 (7) 37/721 (5) 1.5 (0.8 to 2.7)
Smoking 6/69 (9) 10/245 (4) 2.3 (0.7 to 7.1)
Renal disease 9/109 (8) 48/890 (5) 1.6 (0.7 to 3.5)
Age > 80 years 14/186 (8) 44/820 (5) 1.4 (0.7 to 2.8)
Pulmonary oedema 16/216 (7) 42/781 (5) 1.4 (0.7 to 2.6)
Coronary artery disease 42/632 (7) 16/368 (4) 1.8 (0.8 to 3.0)
Previous carcinoma 4/104 (4) 53/887 (6) 0.6 (0.2 to 1.9)
TIA/CVA 3/108 (3) 55/892 (6) 0.4 (0.1 to 1.4)
Male gender 32/530 (6) 26/470 (5) 1.1 (0.6 to 1.9)
LVEF < 50% 8/155 (5) 43/723 (6) 0.9 (0.4 to 2.0)
LV hypertrophy 39/701 (6) 5/77 (6) 0.9 (0.3 to 2.5)
Blood pressure > 140/90 39/654 (6) 19/341 (6) 1.1 (0.6 to 2.0)
Myocardial infarction 8/151 (5) 50/849 (6) 0.9 (0.4 to 2.0)
Atrial fibrillation 12/197 (6) 46/903 (6) 1.1 (0.5 to 2.1)
Diabetes 8/149 (5) 50/851 (6) 0.9 (0.4 to 2.0)
Previous CAS 4/81 (5) 53/916 (6) 0.9 (0.3 to 2.5)
Carotid artery disease 13/238 (5) 43/747 (6) 1.0 (0.5 to 1.9)
Perioperative
Valve size 19 6/37 (16) 52/963 (5) 3.4 (1.2 to 9.0)
Cross clamp time > 60 min 24/460 (6) 8/275 (3) 2.0 (0.9 to 4.9)
Concomitant CABG 41/610 (7) 17/390 (4) 1.6 (0.9 to 2.9)
Procedure on asc. aorta 6/61 (10) 52/939 (6) 1.9 (0.7 to 4.8)
Need for urgent AVR 3/25 (12) 55/975 (6) 2.3 (0.5 to 8.4)
Mitral ring 1/13 (8) 57/987 (6) 1.4 (0.2 to 10.7)
Surgery on carotid artery 1/22 (5) 57/978 (6) 0.8 (0.1 to 5.9)
Postoperative
Heart failure 7/34 (21) 51/966 (5) 4.7 (1.8 to 11.9)
Bleeding 4/20 (20) 54/979 (6) 4.3 (1.2 to 14.3)
Atrial fibrillation 28/381 (7) 30/619 (5) 1.6 (0.9 to 2.7)
COPD = chronic obstructive pulmonary disease, BMI = body mass index, TIA = transient ischaemic attack, CVA = cerebrovascular 
accident, LVEF = left ventricular ejection fraction, CAS = coronary artery surgery, CABG = coronary artery bypass graft, asc. = ascending, 
AVR = aortic valve replacement
Australian Journal of Physiotherapy 2008  Vol. 54  –   © Australian Physiotherapy Association 2008 121
Mistiaen & Vissers: Complications after aortic valve replacement
in the physiotherapy program occurred over the 20 years. 
Preoperative intervention was limited to instruction in the 
use of incentive spirometry. A positive expiratory pressure 
blow bottle was also used postoperatively, unless patients 
had a pneumothorax or subcutaneous emphysema. During 
the stay in the intensive care unit, chest physiotherapy, 
including deep inspiration, inspiratory hold, and percussion, 
as well as mobilisation of the legs in bed occurred twice 
daily. At the ward, this happened once daily under 
supervision of a physiotherapist. Patients were instructed to 
perform exercises hourly. Patients were encouraged to sit 
in a chair from the third day, to walk around in the room 
from the fourth day, and to walk in the corridor from the 
fifth day, the first time under guidance of a physiotherapist. 
After one week, stairs were introduced. If postoperative 
pulmonary complications were diagnosed, physiotherapy 
intervention occurred 2–3 times a day. The effect of 30 
putative predictors on the development of postoperative 
pulmonary and pleural complications was investigated. The 
study was approved by the institutional ethics committee.
Participants
Participants were 1000 consecutive patients who underwent 
aortic valve replacement with a pericardial valve. They were 
referred by cardiologists at the authors’ institution as well 
as from the surrounding hospitals. They represented all the 
patients with aortic valve disease needing valve replacement 
except those with a mechanical valve or a valve in the mitral 
position. Coronary artery surgery was also performed in 
610 patients.
Outcome measures
Thirty putative predictors were identified: 20 were 
preoperative, 7 were perioperative and 3 were postoperative 
(Tables 1 and 3). Carotid artery disease was defined as a 
stenosis over 40% on duplex-doppler and impairment of 
renal function was defined as plasma creatinine over 1.4 
mg/dL. Lung function was assessed with a flow volume 
curve. The test was repeated if the performance was 
technically inadequate. Values of less than 40% of expected 
were considered as ‘positive’ for presence of the putative 
predictor. Smoking was recorded as ‘present’ or ‘absent’. 
Data concerning the length of stay were not available.
Postoperative complications were defined as pulmonary 
or pleural abnormalities occurring within a 30-day 
postoperative period producing clinically significant, 
identifiable disease or dysfunction that adversely affected the 
clinical course. Possible pulmonary complications included 
prolonged mechanical ventilation, respiratory failure 
requiring mechanical or non-invasive positive pressure 
ventilation, pneumonia, or atelectasis requiring intervention. 
Possible pleural complications included pleural effusion, 
pneumothorax, haemothorax, and empyema. Typical 
clinical and radiological signs such as fever, auscultation 
abnormalities, triangular opacification of a segment, or 
a lobe with signs of volume loss (shift of the interlobar 
fissure and sometimes of the mediastinum, accompanied 
with compensatory overinflation of the remaining aerated 
segments) were helpful in the diagnosis of atelectasis. 
CT scan was performed in cases of doubt (Duggan and 
Kavanagh 2005). Awareness of the postoperative risk of 
postoperative pulmonary complications and presence of 
recent preoperative radiographs of the chest for comparison 
were helpful in avoiding misdiagnosis.
Data analysis
All putative predictors were analysed using Fisher’s exact 
and Pearsons’ chi-square (univariate) tests. Significant 
predictors were then used in a stepwise logistic regression 
(multivariate) analysis, to identify the independent 
predictors for postoperative pulmonary complications. 
Dichotomisation of any data for the stepwise logistic 
regression was performed before statistical analysis.
Results
Postoperative pulmonary complications
Postoperative pulmonary complications developed in 
58 (6%) patients. These complications were: prolonged 
mechanical ventilation (n = 19, 2%), respiratory failure 
requiring mechanical or non-invasive positive pressure 
ventilation (n = 6, 1%), pneumonia (n = 22, 2%), or atelectasis 
requiring intervention (28, 3%). Among the 58 patients with 
pulmonary complications, 9 (16%) were fatal, compared 
with 37 (4%) of the 1000 patients in the overall cohort. 
In 6 of the 58, simultaneous complications were recorded 
(heart failure n = 2; renal failure n = 3; bleeding n = 1). To 
1996, 16 of 97 (5%) patients had postoperative pulmonary 
complications, from 1997 on (with the new anaesthetic 
regimen), 42 of 703 (6%) had postoperative pulmonary 
complications which was not significantly different (OR 0.9, 
95% CI 0.5 to 1.7, p = 0.72). Table 1 presents the significance 
of each putative predictor of postoperative pulmonary 
complications. Two preoperative (pacemaker implant, 
chronic obstructive pulmonary disease), one perioperative 
(small valve size), and two postoperative (heart failure 
and bleeding) predictors were significant. Table 2 presents 
the independently-significant predictors of postoperative 
pulmonary complications.
Table 2. Number (%) of patients with pulmonary complications (n = 58) as a proportion of those with and without and odds  
ratios (95% CI) between them for each independent predictor.
Independent predictors Groups Odds ratios between groups
Number with pulmonary 
complications/ 
number with putative 
predictor
Number with pulmonary 
complications/ 
number without putative 
predictor
Proportion of pulmonary 
complications with predictor 
present relative to those with 
predictor absent
Preoperative
Pacemaker implant 7/33 (21) 50/957 (5) 4.4 (1.8 to 11.2)
COPD 21/235 (9) 34/732 (5) 1.7 (1.0 to 3.1)
Postoperative
Heart failure 7/34 (21) 51/966 (5) 4.7 (1.8 to 11.9)
COPD = chronic obstructive pulmonary disease
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The pattern of prediction was similar across patients with 
or without concomitant coronary artery surgery, with the 
exception of chronic obstructive pulmonary disease. In 
patients undergoing aortic valve replacement alone, chronic 
obstructive pulmonary disease did not predict postoperative 
pulmonary complications (OR 0.9, 95% CI 0.2 to 3.1, p = 
0.91), whereas in patients undergoing aortic valve with 
coronary artery surgery it did (OR 2.8, 95% CI 1.4 to 5.8, 
p = 0.002).
Postoperative pleural complications
Postoperative pleural complications developed in 45 (5%) 
patients. These complications were: pleural effusion (n 
= 27, 3%), and pneumothorax (n = 19, 2%). The pleural 
effusion was haemorrhagic in more than half of the cases. 
Postoperative empyema was absent. Pleural complications 
were never fatal when they occurred alone. Only 4 patients 
had both pulmonary and pleural complications. Pleural 
complications were fatal in one patient with bleeding. 
Table 3 presents the significance of each putative predictor 
of postoperative pleural complications. Six preoperative 
predictors (carotid artery disease, previous coronary 
artery surgery, chronic obstructive pulmonary disease, 
conduction defect, body mass index > 25, and age > 80) 
and one postoperative (bleeding) predictor were significant. 
Table 4 presents the independently-significant predictors of 
postoperative pleural complications.
Table 3. Number (%) of patients with pleural complications (n = 45) as a proportion of those with and without and odds ratios 
(95% CI) between them for each putative predictor.
Putative predictors Groups Odds ratios between 
groups
Number with pleural 
complications/ 
number with putative 
predictor
Number with pleural 
complications/ 
number without putative 
predictor
Proportion of pleural 
complications with 
predictor present relative 
to those with predictor 
absent
Preoperative
Carotid artery disease 22/238 (9) 21/747 (3) 3.5 (1.8 to 6.8)
Previous CAS 9/81 (11) 34/916 (4) 3.2 (1.4 to 7.4)
COPD 18/235 (8) 25/732 (3) 2.3 (1.2 to 4.6)
Conduction defect 19/270 (7) 25/721 (3) 2.1 (1.1 to 4.1)
BMI > 25 6/179 (3) 15/134 (11) 0.3 (0.1 to 0.8)
Age > 80 years 15/186 (8) 30/814 (4) 2.3 (1.1 to 4.5)
Blood pressure > 140/90 24/654 (4) 20/341 (6) 0.6 (0.3 to 1.2)
Male gender 20/530 (4) 25/470 (5) 0.7 (0.4 to 1.3)
Pacemaker implant 3/33 (9) 40/957 (4) 2.3 (0.5 to 8.3)
Previous carcinoma 6/104 (6) 37/887 (4) 1.4 (0.5 to 3.6)
LV hypertrophy 32/701 (5) 5/77 (6) 0.7 (0.3 to 2.1)
Pulmonary oedema 11/216 (5) 32/781 (4) 1.3 (0.6 to 2.6)
LVEF < 50% 5/155 (3) 32/723 (4) 0.7 (0.2 to 2.0)
Diabetes 5/149 (3) 40/851 (5) 0.7 (0.3 to 2.0)
Myocardial infarction 8/151 (5) 37/849 (4) 1.2 (0.5 to 2.7)
Renal disease 6/109 (6) 38/809 (5) 1.2 (0.4 to 3.0)
Atrial fibrillation 10/197 (5) 35/803 (4) 1.2 (0.6 to 2.6)
Smoking 5/68 (7) 16/245 (7) 1.1 (0.4 to 3.5)
TIA/CVA 4/108 (4) 41/892 (5) 0.8 (0.2 to 2.4)
Coronary artery disease 28/632 (4) 17/368 (5) 1.0 (0.5 to 1.8)
Operative
Concomitant CABG 22/610 (4) 23/390 (6) 0.6 (0.3 to 1.1)
Cross clamp time > 60 min 15/460 (3) 16/275 (6) 0.6 (0.3 to 2.1)
Surgery on carotid artery 1/22 (5) 44/978 (5) 1.0 (0.1 to 7.3)
Need for urgent AVR 1/25 (4) 44/975 (5) 0.8 (0.1 to 7.5)
Valve size 19 1/37 (3) 44/963 (5) 0.6 (0.2 to 25.6)
Procedure on asc. aorta 3/61 (5) 42/939 (4) 1.1 (0.3 to 3.8)
Mitral ring 1/13 (8) 44/987 (4) 1.8 (0.2 to 15.6)
Postoperative
Bleeding 4/20 (20) 41/979 (4) 5.7 (1.6 to 19.3)
Atrial fibrillation 16/381 (4) 29/619 (5) 0.9 (0.5 to 1.7)
Heart failure 2/34 (6) 43/966 (4) 1.3 (0.2 to 4.5)
CAS = coronary artery surgery, COPD = chronic obstructive pulmonary disease, BMI = body mass index, LV = left ventricular, LVEF = left 
ventricular ejection fraction, TIA = transient ischaemic attack, CVA = cerebrovascular accident, CABG = coronary artery bypass graft,  
AVR = aortic valve replacement, asc. = ascending 
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Discussion
The incidence of postoperative complications in our series 
was 6% for pulmonary and 5% for pleural complications. 
We were unable to find comparable reports of overall 
postoperative pulmonary and pleural complication rates 
after aortic valve replacement, to which we could compare 
our results. The incidence of some specific complications 
have, however, been reported. For example, the incidence 
of prolonged ventilation has been identified at 2 in 40 (5%) 
(Bonacchi et al 2002), respiratory failure at 2 in 40 (5%) 
(Bonacchi et al 2002), and pneumothorax at 1 in 25 (4%) 
(Christiansen et al 1999). Slight differences in incidence 
between our data and these published reports may reflect 
the differences in populations, exact surgical technique, or 
concomitant management. However, we are confident that 
our dataset of 1000 cases provides more accurate estimates 
than previous reports.
Similarly, no published analysis of risk factors was found 
for complications after aortic valve replacement specifically. 
We do not consider it appropriate to compare our data to 
risk factors previously identified for general cardiac or other 
surgical populations. For example, in contrast to coronary 
artery surgery, extracorporeal circulation is always required 
for aortic valve replacement, with alterations of lung 
function, reduction in lung compliance or gas exchange, 
increase in lung vascular permeability, atelectasis, and adult 
respiratory distress syndrome. Extracorporeal circulation 
can induce systemic inflammation as well as imbalance of 
oxidant/antioxidant and protease/antiprotease status. These 
changes have been implicated in pulmonary complications 
(Staton et al 2005). There is also a possible interaction 
between the extracorporeal circulation and the effect of 
body mass: in small patients, hemodilution is usually 
greater since the circuit prime represents a greater fraction 
of the circulating blood-prime mixture. This might increase 
the oncotic gradient, extravasation, pulmonary oedema, 
and pneumonia, especially with injured endothelial cells 
(Habib et al 2005). Pulmonary oedema is also a hallmark 
of postoperative heart failure, which is a clear risk factor for 
postoperative pulmonary complications in our series.
Remarkably, the preoperative implant of a pacemaker 
was identified as an important predictor for postoperative 
pulmonary complications in the current series. There 
is probably no direct relation between the implant and 
postoperative pulmonary complications. However, need 
for a pacemaker could serve as a marker for an advanced 
heart disease, especially in the presence of a calcified 
aortic stenosis. This, in turn could affect the postoperative 
course.
Chronic obstructive pulmonary disease was already known 
to be a risk factor for the formation of bullae, especially 
in the presence of emphysema. A tear can result in a 
pneumothorax. Chronic obstructive pulmonary disease was 
also identified in the current series as a risk factor for both 
pulmonary and pleural complications. It appears that use 
of an internal mammary artery is associated with a higher 
prevalence of pleural effusion (Light et al 2002). This was 
avoided as much as possible in our patients. With opening 
of the pleural cavity and removal of the internal mammary 
artery, a raw surface is left in the thoracic cavity with an 
increased risk for hemorrhagic effusion, when warfarin is 
started from the third postoperative day. Internal mammary 
artery harvesting is also associated with a higher incidence 
of new musculoskeletal and neurological complications 
than is saphenous vein grafting (El-Ansary et al 2000).
At least 40% of patients who undergo coronary artery 
bypass surgery develop a pleural effusion in the immediate 
postoperative period. Most of the effusions are small and 
left-sided. The natural history of these effusions is that the 
majority resolve and do not result in patient morbidity. The 
effusions usually resolve with one or two thoracenteses, 
but occasionally several thoracenteses are required. The 
effusions resolve within 1 year of surgery in almost all 
patients (Light et al 2002).
With identification of risk factors for postoperative pulmonary 
complications after aortic valve replacement, the effect of 
preventive measures (increased use of breathing exercises, 
incentive spirometry and positive expiratory pressure) 
can now be studied to determine whether a preoperative 
program and postoperative intervention is beneficial in 
patients at risk. Voluntary deep-breathing exercises and use 
of a blow bottle on the second day after coronary artery 
surgery have been shown to have an immediate effect 
on atelectasis and spirometric values, forced expiratory 
capacity and FEV1 (Westerdahl et al 2005). These effects 
are not, however, sufficient for more intensive postoperative 
physiotherapy to reduce the incidence of postoperative 
pulmonary complications after routine cardiac surgery 
(Stiller et al 1994, Brasher et al 2003).
Table 4. Number (%) of patients with pleural complications (n = 45) as a proportion of those with and without and odds ratios 
(95% CI) between them for each independent predictor.
Independent predictors Groups Odds ratios between groups
Number with pleural 
complications/ 
number with putative 
predictor
Number with pleural 
complications/ 
number without putative 
predictor
Proportion of pleural 
complications with predictor 
present relative to those with 
predictor absent
Preoperative
Carotid artery disease 22/238 (9) 21/747 (3) 2.8 (1.4 to 5.5)
Previous CAS 9/81 (11) 34/916 (4) 2.7 (1.1 to 6.4)
COPD 18/235 (8) 25/732 (3) 1.9 (1.0 to 3.8)
Conduction defect 19/270 (7) 25/721 (3) 1.9 (1.0 to 3.7)
Postoperative
Bleeding 4/20 (20) 41/979 (4) 7.4 (1.8 to 29.9)
CAS = coronary artery surgery, COPD = chronic obstructive pulmonary disease
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In terms of management of patients undergoing aortic 
valve replacement, it is reasonable in the first place to 
encourage early mobilisation. Second, modifiable risk 
factors should be minimised, such as quitting smoking 
in order to allow the respiratory epithelium to recover. 
In the case of severely symptomatic aortic valve disease, 
however, the risk of developing an urgent need for aortic 
valve replacement outweighs the risk due to active smoking, 
hence the operation should not be postponed (Mistiaen et al 
2004). Third, for patients with non-modifiable risk factors 
such as chronic obstructive pulmonary disease, previously 
implanted pacemakers, or previously performed coronary 
artery surgery, the effect of preventive preoperative and 
more intensive postoperative should be studied.
A limitation of this study was the unavailability of data on the 
length of stay. This measure reflects the postoperative course 
after aortic valve replacement. However, prolonged stay can 
also be the consequence of postoperative complications that 
are not pulmonary or pleural in nature. Another limitation 
is the incompleteness of the data, although every effort was 
made to obtain complete data. For 24 factors, completeness 
of over 99% was achieved. Due to changes in the recording 
of data over 20 years, data concerning smoking habits and 
of body mass index are incomplete. This is true to a lesser 
degree for estimation of left ventricular ejection fraction, 
left ventricular hypertrophy, and cross clamping time. This 
makes the statistical analysis less powerful.
In conclusion, several risk factors for postoperative compli-
cations have been identified which should be noted by 
physiotherapists responsible for patients after aortic valve 
surgery. Although any immediate physiological benefits 
of routine physiotherapy (other than mobilisation) may not 
be sufficient to reduce postoperative complications, the 
risk factors identified in this study may define a subgroup 
of patients with more to gain from such interventions. 
We suggest that this population should be studied to see 
if they are responsive to preoperative and postoperative 
physiotherapy.
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